share_log
Breakings ·  Oct 30 12:29
Biomarin Pharmaceutical Inc : Leerink Partners Cuts Target Price to $105 From $132
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment